Hypomethylating Agents and Epigenetic Combination Therapies Transforming the Decitabine Drug Market
Targeting DNA hypermethylation to reactivate silenced tumor-suppressor genes represents a foundational strategy across hematological oncology within the global Decitabine Drug Market. Decitabine (5-aza-2'-deoxycytidine) acts as a potent cytidine analog that incorporates into DNA during replication, irreversibly inhibiting DNA methyltransferase (DNMT) enzymes. Inducing global DNA hypomethylation...
0 Comments 0 Shares 85 Views 0 Reviews